Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ritu Kumar

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Stem Cell Research|October 23, 2025
Derivation of pluripotent stem cell lines (RFSCi005-A, RFSCi006-A) from siblings harboring identical high-risk complement variants with discordant age-related macular degenerationNaresh Rajendran, Ajeet Singh, Wendy Runyon, et al.
Stem Cell Research|July 8, 2025
Generation of induced pluripotent stem cell lines (RFSCi003-A, RFSCi004-A) from monozygotic twins discordant for age-related macular degenerationNaresh Rajendran, Wendy Runyon, Sam Hu, et al.
Plos One|September 15, 2010
Adverse events in a cohort of HIV infected pregnant and non-pregnant women treated with nevirapine versus non-nevirapine antiretroviral medicationErika Aaron, Mirjam-Colette Kempf, Shannon Criniti, et al.
Clinical Breast Cancer|March 21, 2009
Survival outcomes for patients with metastatic triple-negative breast cancer: implications for clinical practice and trial designFarrah Kassam, Katherine Enright, Rebecca Dent, et al.
Stem Cell Research|April 24, 2025
Generation of human induced pluripotent stem cell lines from an age-related macular degeneration patient with hyperreflective foci overlying drusen (RFSCi002-A) and an unaffected sibling (RFSCi001-A)Adnin Ashrafi, Wendy Runyon, Sam Hu, et al.
Stem Cell Research|October 31, 2025
Generation of iPSCs (RFSCi007-A, RFSCi008-A) from a patient with early-onset bilateral drusen and a healthy sibling for retinal disease modelingSonali Singh, Wendy Runyon, Sam Hu, et al.
Bulletin of the World Health Organization|April 20, 2013
Scale-up of a comprehensive harm reduction programme for people injecting opioids: lessons from north-eastern IndiaMelody Lalmuanpuii, Langkham Biangtung, Ritu Kumar Mishra, et al.
Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment|September 18, 2024
Infant nutrition at risk: a global systematic review of ochratoxin A in human breast milk-human health risk assessmentMohammad Shakil Ahmad, Yousef Abud Alanazi, Yousef Alrohaimi, et al.
Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment|July 15, 2024
Occurrence, evaluation, and human health risk assessment of ochratoxin a in infant formula and cereal-based baby food: a global literature systematic reviewMohammad Shakil Ahmad, Yousef Abud Alanazi, Yousef Alrohaimi, et al.
BMC Infectious Diseases|February 5, 2025
The impact of delay in HIV diagnosis on patient survival: analysis of HIV infection trends from 2007 to 2023Riyaz A Shaik, Sharan K Holyachi, Mohammad S Ahmad, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Stem Cell Research|October 23, 2025
Derivation of pluripotent stem cell lines (RFSCi005-A, RFSCi006-A) from siblings harboring identical high-risk complement variants with discordant age-related macular degenerationNaresh Rajendran, Ajeet Singh, Wendy Runyon, et al.
Stem Cell Research|July 8, 2025
Generation of induced pluripotent stem cell lines (RFSCi003-A, RFSCi004-A) from monozygotic twins discordant for age-related macular degenerationNaresh Rajendran, Wendy Runyon, Sam Hu, et al.
Plos One|September 15, 2010
Adverse events in a cohort of HIV infected pregnant and non-pregnant women treated with nevirapine versus non-nevirapine antiretroviral medicationErika Aaron, Mirjam-Colette Kempf, Shannon Criniti, et al.
Clinical Breast Cancer|March 21, 2009
Survival outcomes for patients with metastatic triple-negative breast cancer: implications for clinical practice and trial designFarrah Kassam, Katherine Enright, Rebecca Dent, et al.
Stem Cell Research|April 24, 2025
Generation of human induced pluripotent stem cell lines from an age-related macular degeneration patient with hyperreflective foci overlying drusen (RFSCi002-A) and an unaffected sibling (RFSCi001-A)Adnin Ashrafi, Wendy Runyon, Sam Hu, et al.
Stem Cell Research|October 31, 2025
Generation of iPSCs (RFSCi007-A, RFSCi008-A) from a patient with early-onset bilateral drusen and a healthy sibling for retinal disease modelingSonali Singh, Wendy Runyon, Sam Hu, et al.
Bulletin of the World Health Organization|April 20, 2013
Scale-up of a comprehensive harm reduction programme for people injecting opioids: lessons from north-eastern IndiaMelody Lalmuanpuii, Langkham Biangtung, Ritu Kumar Mishra, et al.
Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment|September 18, 2024
Infant nutrition at risk: a global systematic review of ochratoxin A in human breast milk-human health risk assessmentMohammad Shakil Ahmad, Yousef Abud Alanazi, Yousef Alrohaimi, et al.
Food Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment|July 15, 2024
Occurrence, evaluation, and human health risk assessment of ochratoxin a in infant formula and cereal-based baby food: a global literature systematic reviewMohammad Shakil Ahmad, Yousef Abud Alanazi, Yousef Alrohaimi, et al.
BMC Infectious Diseases|February 5, 2025
The impact of delay in HIV diagnosis on patient survival: analysis of HIV infection trends from 2007 to 2023Riyaz A Shaik, Sharan K Holyachi, Mohammad S Ahmad, et al.
Pageof 5